Nicholas Dawson

The new Wegovy pill, recently authorised by the UK medicines regulator, offers a more convenient weight‑loss option than injectable GLP‑1 treatments, particularly for travellers since it does not require refrigeration. CheqUp pharmacist Aaron Arman emphasises the ease of transporting the tablets, while CEO Lisa Tookey notes that pills reduce logistical and emotional challenges associated with injections. A survey of injectable users found that many altered or cancelled travel plans due to concerns about managing their medication, highlighting the significance of the pill’s portability.

Experts outline key differences between the Wegovy weight loss pill and injection, highlighting the need to take the pill on an empty stomach with water and wait 30 minutes before eating or taking other medications. Switching from injections is not considered a step down, and clinicians can determine the correct equivalent dose for the transition. Temporary appetite changes or increased indigestion may occur as the body adjusts, with over‑the‑counter remedies suggested for relief. Patients are advised not to combine the pill with other GLP‑1 treatments, with a recommended seven‑day gap between stopping injections and starting tablets.

Proposals to overhaul UK TV licence regulations are advancing, with campaigners calling for a referendum on whether to abolish the £180 annual fee. A petition argues the public should decide on the licence’s future, while another petition gaining significant support demands free licences for all pensioners. Current rules restrict free licences to those over 75 receiving Pension Credit, along with some individuals with specific medical conditions. The BBC relies heavily on licence fee income, which funds its programming, the World Service, S4C, and Local Democracy Reporters, and allows its UK services to remain free of advertising and political influence.